Wenjun Guo

Wenjun Guo

Auto-generated profile, based on publicly available information

Wenjun Guo

Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA, 02142, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2011 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
CMCaitlin D May
Caitlin D May
NSNATHALIE SPHYRIS
NATHALIE SPHYRIS
KEKurt W Evans
Kurt W Evans
SWSteven J Werden
Steven J Werden
WGWenjun Guo
Wenjun Guo
SMSendurai Mani
Sendurai Mani
Aberrant activation of a latent embryonic program - known as the epithelial-mesenchymal transition (EMT) - can endow cancer cells with the migratory and invasive capabilities associated with metastatic competence. The induction of EMT entails the loss of epithelial characteristics and the de novo acquisition of a mesenchymal phenotype. In breast cancer, the EMT state has been associated with cancer stem cell properties including expression of the stem cell-associated CD44+/CD24-/low antigenic profile, self-renewal capabilities and resistance to conventional therapies. Intriguingly, EMT features are also associated with stem cells isolated from the normal mouse mammary gland and human breast reduction tissues as well as the highly aggressive metaplastic and claudin-low breast tumor subtypes. This has implications for the origin of these breast tumors as it remains unclear whether they derive from cells that have undergone EMT or whether they represent an expansion of a pre-existing stem cell population that expresses EMT-associated markers to begin with. In the present review, we consider the current evidence connecting EMT and stem cell attributes and discuss the ramifications of these newly recognized links for our understanding of the emergence of distinct breast cancer subtypes and breast cancer progression.